Filing Details
- Accession Number:
- 0001615774-18-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-03 06:05:24
- Reporting Period:
- 2018-01-02
- Accepted Time:
- 2018-01-03 06:05:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1621443 | Zynerba Pharmaceuticals Inc. | ZYNE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1405685 | Michael Rapp | 9701 Collins Avenue, #1902-S Bal Harbor FL 33154 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-02 | 15,000 | $12.99 | 1,469,115 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 80,467 shares transferred by Broadband Capital Management LLC ("BCM") to Reporting Person for no consideration. The Reporting Person was the Chairman and member of BCM.
Billionaire Hedge Funds
